| Laura Newey, NP | |
|
4 Tower Place, 8th Floor, Albany, NY 12203-3715 | |
| (518) 489-4471 | |
| (518) 489-4506 |
| Full Name | Laura Newey |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 4 Tower Place, Albany, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083073373 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 340357 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saratoga Hospital | 6406740273 | 314 |
News Archive
The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.
"A month after Typhoon Bopha hit the southern Philippines, up to one million people need food assistance and thousands of others could be displaced for a second time, the United Nations says," AlertNet reports.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
The results of a randomized, double-blind, placebo-controlled clinical trial showed that Cognizin citicoline (Jarrow Formulas) was effective at reducing cocaine use, based on urine drug screens, in patients with bipolar disorder and cocaine dependence. The study, published in the American Journal of Psychiatry in Advance, included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin citicoline or placebo add-on therapy for 12 weeks.
› Verified 1 days ago
| Entity Name | Saratoga Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033371166 PECOS PAC ID: 6406740273 Enrollment ID: O20040402000837 |
News Archive
The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.
"A month after Typhoon Bopha hit the southern Philippines, up to one million people need food assistance and thousands of others could be displaced for a second time, the United Nations says," AlertNet reports.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
The results of a randomized, double-blind, placebo-controlled clinical trial showed that Cognizin citicoline (Jarrow Formulas) was effective at reducing cocaine use, based on urine drug screens, in patients with bipolar disorder and cocaine dependence. The study, published in the American Journal of Psychiatry in Advance, included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin citicoline or placebo add-on therapy for 12 weeks.
› Verified 1 days ago
| Entity Name | The Center For Rheumatology Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205926078 PECOS PAC ID: 5395788327 Enrollment ID: O20050609000902 |
News Archive
The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.
"A month after Typhoon Bopha hit the southern Philippines, up to one million people need food assistance and thousands of others could be displaced for a second time, the United Nations says," AlertNet reports.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
The results of a randomized, double-blind, placebo-controlled clinical trial showed that Cognizin citicoline (Jarrow Formulas) was effective at reducing cocaine use, based on urine drug screens, in patients with bipolar disorder and cocaine dependence. The study, published in the American Journal of Psychiatry in Advance, included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin citicoline or placebo add-on therapy for 12 weeks.
› Verified 1 days ago
| Entity Name | Healthcare Partners Of Saratoga Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700159613 PECOS PAC ID: 9739320938 Enrollment ID: O20130731000462 |
News Archive
The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.
"A month after Typhoon Bopha hit the southern Philippines, up to one million people need food assistance and thousands of others could be displaced for a second time, the United Nations says," AlertNet reports.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
The results of a randomized, double-blind, placebo-controlled clinical trial showed that Cognizin citicoline (Jarrow Formulas) was effective at reducing cocaine use, based on urine drug screens, in patients with bipolar disorder and cocaine dependence. The study, published in the American Journal of Psychiatry in Advance, included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin citicoline or placebo add-on therapy for 12 weeks.
› Verified 1 days ago
| Entity Name | Saratoga Regional Medical , P.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982094827 PECOS PAC ID: 9032438544 Enrollment ID: O20150505002182 |
News Archive
The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.
"A month after Typhoon Bopha hit the southern Philippines, up to one million people need food assistance and thousands of others could be displaced for a second time, the United Nations says," AlertNet reports.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
The results of a randomized, double-blind, placebo-controlled clinical trial showed that Cognizin citicoline (Jarrow Formulas) was effective at reducing cocaine use, based on urine drug screens, in patients with bipolar disorder and cocaine dependence. The study, published in the American Journal of Psychiatry in Advance, included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin citicoline or placebo add-on therapy for 12 weeks.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Newey, NP 6 Care Ln, Saratoga Springs, NY 12866-8651 Ph: (518) 584-4953 | Laura Newey, NP 4 Tower Place, 8th Floor, Albany, NY 12203-3715 Ph: (518) 489-4471 |
News Archive
The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.
"A month after Typhoon Bopha hit the southern Philippines, up to one million people need food assistance and thousands of others could be displaced for a second time, the United Nations says," AlertNet reports.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
The results of a randomized, double-blind, placebo-controlled clinical trial showed that Cognizin citicoline (Jarrow Formulas) was effective at reducing cocaine use, based on urine drug screens, in patients with bipolar disorder and cocaine dependence. The study, published in the American Journal of Psychiatry in Advance, included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin citicoline or placebo add-on therapy for 12 weeks.
› Verified 1 days ago
Denise Ayers, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 75 New Scotland Ave, Albany, NY 12208 Phone: 518-447-9611 | |
Natalia Gyorke, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd, Albany, NY 12205 Phone: 518-453-9088 Fax: 518-689-6111 | |
Ms. Veronica Elaine Striffler, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1375 Washington Ave Ste 101, Albany, NY 12206 Phone: 518-438-4483 Fax: 518-482-4201 | |
Courtney Cassandra Peck, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6 Executive Park Dr, Albany, NY 12203 Phone: 518-641-6319 Fax: 518-641-6850 | |
Ms. Susan E Macknair, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 62 Hackett Blvd, Albany, NY 12209 Phone: 518-465-3318 Fax: 518-272-7458 | |
Robin M Gray, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-3480 Fax: 518-262-0135 | |
Kelly Irwin Pagnotti, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1550 |